| name | Fluticasone Propionate/Salmeterol (e.g., Advair) |
| classification | Combination Inhaled Corticosteroid/Long-Acting Beta-2 Agonist |
| pharmacokinetics | | absorption | Fluticasone propionate is absorbed locally in the lungs, with minimal systemic absorption. Salmeterol is primarily absorbed in the lungs and systemic circulation. | | distribution | Distribution is primarily to the respiratory system. Systemic distribution depends on the specific agent and patient factors like age, hepatic, and renal function. | | metabolism | Metabolism largely occurs in the liver. Fluticasone propionate metabolism is predominantly hepatic. Salmeterol metabolism is hepatic and partly via the lungs. | | excretion | Excretion is primarily through the kidneys and lungs, influenced by hepatic and renal function. |
|
| suggested dosage | Dosage varies. Consult the prescribing physician's instructions, which will include specific dose and frequency for this Fluticasone Propionate/Salmeterol combination. Do not adjust dosage without consulting a healthcare professional. |
| indications | | 1 | Treatment and prevention of asthma | | 2 | Treatment of chronic obstructive pulmonary disease (COPD) |
|
| safety in pregnancy | Limited data exists. Consult a physician. Potential benefits should be weighed against the potential risks to the developing fetus. |
| safety in breastfeeding | Limited data exists. Consult a physician. Potential risks and benefits must be evaluated by a healthcare professional. |
| side effects | | 1 | | category | Inhaled Corticosteroid (ICS) Related | | effects | | 1 | Oropharyngeal candidiasis (thrush) | | 2 | Hoarseness | | 3 | Cough | | 4 | Dysphonia | | 5 | Increased risk of pneumonia (especially in high-risk patients) |
|
| | 2 | | category | Long-Acting Beta-2 Agonist (LABA) Related | | effects | | 1 | Tremor | | 2 | Nervousness | | 3 | Headache | | 4 | Elevated heart rate | | 5 | Anorexia/Appetite Changes | | 6 | Insomnia (if given too late at night) |
|
|
|
| alternatives | |
| contraindications | | 1 | Hypersensitivity to any component of the medication | | 2 | Uncontrolled severe heart conditions |
|
| interactions | Potential interactions with other medications. Consult a healthcare professional. |
| warnings and precautions | | 1 | Proper inhaler technique is crucial to minimize side effects. Regular monitoring of lung function is often necessary. | | 2 | Increased risk of pneumonia and other respiratory infections possible with certain medications and high dosage. | | 3 | Patients with a history of severe cardiovascular diseases should be monitored closely. | | 4 | Patients with a history of peptic ulcer disease should be monitored closely. |
|
| additional informations | | patient age and weight considerations | Patient age (25) and weight (70 kg) are factors for dosage. The patient should be monitored for individual response and potential side effects. | | inhaler education | Patients must receive proper training on the use of inhalers to ensure effective medication delivery. |
|
| patient specific notes | This information is for educational purposes only and does not constitute medical advice. It is essential to consult with a healthcare professional for personalized recommendations and treatment. |
